Roivant Sciences Ltd.
ROIV NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 6, 2026
ET
EPS Est.
-0.30
EPS Actual
-0.33
Revenue Est.
$2.1M
Revenue Actual
$1.4M
Next Earnings Report Date unconfirmed
Date
Nov 9, 2026 · Mon
ET Nov 9, 2026 · Mon
Time
11/9 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q2
EPS Est.
-0.41
Revenue Est.
$3.7M
Company Overview
Roivant Sciences Ltd. (ticker ROIV) is listed on NASDAQ with a market cap of about $25.8B. Its next earnings report (FY2026 Q2) is expected on Nov 9, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.41. In the last 15 reported quarters, EPS beat consensus estimates 9 times.
Actual EPS TrendRecently15Term · Feb 13, 2023 → Aug 6, 2026
Feb 13, 2023Range: -0.49 ~ 0.12Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.30 | Below forecast↓-0.33 | $2.1M | $1.4M |
| May 20, 2026 | -- | -0.29 | Above forecast↑-0.28 | $3.4M | $2.5M |
| Feb 6, 2026 | -- | -0.30 | Above forecast↑-0.24 | $5.1M | $2M |
| Nov 10, 2025 | -- | -0.32 | Above forecast↑-0.20 | $5.6M | $1.6M |
| Aug 11, 2025 | -- | -0.25 | -0.25 | $7.3M | $2.2M |
| May 29, 2025 | -- | -0.26 | Below forecast↓-0.29 | $54.1M | $7.6M |
| Feb 10, 2025 | -- | -0.25 | Above forecast↑-0.23 | $5M | $9M |
| Nov 12, 2024 | -- | -0.25 | Below forecast↓-0.29 | $45.9M | $4.5M |
| Aug 8, 2024 | -- | -0.24 | Above forecast↑0.12 | $30.7M | $55.1M |
| May 30, 2024 | -- | -0.26 | Above forecast↑-0.23 | $31M | $28.9M |
| Feb 13, 2024 | -- | -0.31 | Above forecast↑-0.21 | $31.8M | $37.1M |
| Nov 13, 2023 | -- | -0.28 | Above forecast↑-0.26 | $27.1M | $37.1M |
| Aug 14, 2023 | -- | -0.30 | Below forecast↓-0.38 | $24.5M | $21.6M |
| Jun 28, 2023 | -- | -0.41 | Above forecast↑-0.20 | $18.2M | $27.4M |
| Feb 13, 2023 | -- | -0.36 | Below forecast↓-0.49 | $14.8M | $17.1M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-06 ↗
Earnings Release8-K · 2026-08-06 ↗
Annual10-K · 2026-05-20 ↗
Earnings Release8-K · 2026-05-20 ↗
Quarterly10-Q · 2026-02-06 ↗
Earnings Release8-K · 2026-02-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
